Just a small breather at 0.65c. I believe the annual report is due in about 10 days... hopefully there will be some guidance in that! The waiting game is on for now... key milestones are the approval of patents in India & Hong Kong, the USA FDA approval, then we await the distribution/royalty agreements with the global pathology players. Janssen will likely want to secure a longer term exclusive deal as a complementary diagnostic. Given the persistently low market cap of PIQ a takeover bid is also a possibility, the stock has a very bright future & it is tightly held by management - I would be surprised if a bid were to be accepted.
Just a small breather at 0.65c. I believe the annual report is...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $53.14M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $75.67K | 227.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9093 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 2200 | 1 |
View Market Depth
| Last trade - 15.02pm 24/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |